is tirzepatide off the shortage list Compounders protest as FDA removes Mounjaro and Zepbound no longer

For currently FDA-approved options in type 2 diabetes and weight management, healthcare providers may discuss medications and trial programs such as tirzepatide, semaglutide, dulaglutide, and liraglutide depending on indication, label, contraindications, insurance coverage, and clinical context

Increased Risk of Hypoglycemia Even if you do not have diabetes, your blood sugar can drop too low

Clinical studies have shown that tirzepatide can lead to greater weight loss compared to other GLP-1 medications

Improved quality of life: Semaglutide can help improve overall quality of life by reducing the burden of obesity and related health conditions.